Nov-Dec 2017


Elekta and Brainlab collaborate to streamline treatment workflows for stereotactic radiation therapy

Integration of Versa HD linear accelerator and ExacTrac empowers clinicians to optimize radiation therapy inside and outside the brain

Elekta (EKTA-B.ST) and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD™ linear accelerator and Brainlab ExacTrac® patient positioning and monitoring technology. The integration of these two technologies offers high definition stereotactic radiosurgery (HDRS) treatments with versatile patient positioning and monitoring through simplified workflows.

For the first time, a Versa HD system augmented with ExacTrac was displayed at the Elekta booth during the American Society for Radiation Oncology (ASTRO) Annual Meeting, in September in San Diego. The number of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) procedures is expected to increase dramatically between 2014 and 2024 (70% and 103%, respectively). This growth is substantially larger than the estimated increase in the number of patients estimated for these treatments (22% and 26%, respectively), reflecting the wider adoption of stereotactic radiation to treat intra- as well as extra-cranial tumours. Innovative workflows that address the challenges associated with using these procedures for different anatomies are essential to ensuring a high degree of safety, efficacy and efficiency.

In line with the growing adoption of radiosurgery, the Versa HD HDRS and ExacTrac solution will provide clinicians the following benefits:

  • Support the delivery of high definition stereotactic treatments in standard treatment slots, regardless of tumor complexity or anatomy
  • Frameless stereotactic solutions for multiple anatomical applications
  • Integrated workflows and robust image guidance and motion management during delivery for coplanar and non-coplanar treatments

Nearly 70 leading cancer centres across the globe have acknowledged and utilized the mutual benefits of Versa HD together with ExacTrac.

Ludwig-Maximilian University (LMU) Hospital in Munich has used the integrated system for more than two years. “The integration of Versa HD and ExacTrac enables a seamless workflow that allows us to improve patient comfort while reducing treatment time,” said Professor Claus Belka, MD, Director Department of Radiation Oncology at LMU. “Combined, these technologies give us the flexibility to treat complex tumours that require extremely precise targeting using the same systems with which we treat more conventional cases. This helps us to reduce the cost of delivering quality care to all of our patients.”

The companies have a history of collaborating to provide innovative solutions to not only the radiosurgery community but also neurosurgery. In September 2016, the companies announced an agreement designed to ensure the continuous evolution of interoperability and safety of Elekta’s Leksell® Vantage™ Stereotactic System and Elements Stereotaxy treatment planning and verification software from Brainlab. The integrated use of both systems is designed to improve the safety and accuracy of stereotactic neurosurgical procedures. In June 2017, the companies announced that Brainlab would be the authorized distributor of Elekta’s stereotactic solutions for neurosurgery in selected markets.

“The combination of these technologies will help advance the care and outcomes of patients undergoing SRT and may make this important treatment option available to more patients,” said Maurits Wolleswinkel, Elekta’s Chief Strategy Officer. “We are pleased to expand our collaboration with Brainlab, a company that shares our commitment to using innovation to improve patients’ lives and increase the efficiency and efficacy of the radiation therapy treatment continuum.”

“Brainlab has always strived to provide streamlined treatment workflows and solutions to improve cancer treatments for patients. Intra-operability with various delivery systems was key for Brainlab to achieve that,” commented Claus Promberger, Director Product Definition at Brainlab. “The partnership with Elekta is a great testimony to the potential of ExacTrac as a versatile and precise patient monitoring and positioning system.”

Timesco Callisto Flare preloaded LED single-use handles

Over the past decade Timesco has become market leader in the field of laryngoscopy with an unrivalled range of quality brands; reusable: fibre Optima, Sirius, standard Orion and single use: fi bre Callisto, Freeway and standard Europa light.

Timesco’s range of laryngoscopes have been further upgraded with the addition of an LED light for the reusable and single-use handles and standard blades.

The single-use Callisto range has been expanded with the addition of Callisto Flare LED single-use dry cell and preloaded handles which are supplied complete with batteries. The Callisto Flare LED handles are available individually and also paired with the Callisto blades, Freeway blades as handle and blade packs, ready to use.

Timesco’s Callisto and Freeway single-use laryngoscopes offer control of cross contamination, no reprocessing or autoclaving costs and convenience. In a recent study in USA comparing costs of the reprocessing of reusable and single-use laryngoscopes it was found that the reprocessing cycle cost for reusable blades and handles was $17 and if there was a Hospital Acquired Infection the cost would increase to $27.

The Callisto system is latex free, non toxic and can be disposed in standard hospital waste. Timesco products are ISO, CE, FDA, SFDA, etc, worldwide approved.

World’s first cochlear implant powered by wireless charging launched by MED-EL

MED-EL, the leading provider of hearing implant systems, has launched the world’s first cochlear implant audio processor to feature wireless charging. Utilising a ground-breaking design, the RONDO 2 frees implant users from the need to regularly replace batteries, making the device easy to use, more cost effective and friendlier to the environment.

Wireless charging allows users to power their implant with 18 hours of battery life for four-hour charge, giving users a full day of hearing from one overnight charge. It also saves users the hassle of replacing the disposable batteries that power the device. In a single year, powering the device every day would require more than 700 batteries, which is not necessary anymore.

“We are so used to charging our devices at home overnight,” says David Raetz, CEO MED-EL Middle East. “We charge phones and tablets this way, so why not audio processors? It’s the next logical step for cochlear implants and we are so excited to be pioneering the way forward.”

Cochlear implants are small implantable devices that allow people with profound hearing loss to experience the sensation of sound by electrically stimulating the inner ear. RONDO 2 is theexternal part of the implant, attached magnetically on the head, and functions as an audio processor, picking up and transmitting sound to the internal implant. The RONDO 2 uniquely combines a transmitter coil, control unit and power source into a single device – a single unit processor – meaning it can be worn with glasses or hidden completely under hair.

RONDO 2, and its accessories, will be available in the region from the end of 2017.

Introducing the new POC Connect data management solution for the DiaSpect haemoglobin analyser

POC Connect is the world’s first mobile data management solution designed for a reagent free haemoglobin testing device.

The simple android application enables you to store, access and transmit haemoglobin results directly from a DiaSpect Tm haemoglobin analyser to a smartphone via Bluetooth® technology.

All you need is an android phone and a ‘DiaSpect’ device and you are able to record haemoglobin results and link with unique IDs, QC information, Cuvette LOT numbers, comments and dates andtimes. Flexible configuration options allow you to customize the recorded data per your needs. This data is held in a history list that can be transferred easily via a file download or through email to a central database or lab information system (LIS).

The DiaSpect device can be purchased with integrated Bluetooth, meaning there is no need to purchase an additional external Bluetooth dongle. This new solution will prove useful in countries with challenging environmental and geographical conditions where remote haemoglobin testing and access to internet can often be challenging.




Date of upload: 22nd Sep 2017

                                                                        Copyright © 2017 All Rights Reserved.